| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Neal L Benowitz | |
| Jack E Henningfield | |||
| P2860 | cites work | Nicotine reduction revisited: science and future directions | Q36201699 |
| Nicotine reduction: strategic research plan | Q36823218 | ||
| Effects of low nicotine content cigarettes on smoke intake | Q44941683 | ||
| Establishing a nicotine threshold for addiction. The implications for tobacco regulation | Q46058830 | ||
| Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette | Q46897472 | ||
| Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days | Q48418098 | ||
| The emerging market for long-term nicotine maintenance | Q73744905 | ||
| Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface | Q77795536 | ||
| Tobacco product regulation: context and issues | Q77795545 | ||
| Tobacco-dependence medications: public health and regulatory issues | Q77795549 | ||
| WHO Study Group on Tobacco Product Regulation. Report on the scientific basic of tobacco product regulation: fourth report of a WHO study group | Q84939480 | ||
| Protocol to eliminate illicit trade in tobacco products opened for signature | Q95553199 | ||
| Abuse liability assessment of tobacco products including potential reduced exposure products | Q33559301 | ||
| Principles of laboratory assessment of drug abuse liability and implications for clinical development | Q34981070 | ||
| Reducing tobacco addiction through tobacco product regulation | Q35539004 | ||
| Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association | Q35573356 | ||
| Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes | Q35947187 | ||
| Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. | Q36047601 | ||
| The reinforcement threshold for nicotine as a target for tobacco control | Q36164835 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P921 | main subject | tobacco product | Q44106 |
| tobacco use disorder | Q152100 | ||
| (−)-nicotine | Q28086552 | ||
| P304 | page(s) | i14-7 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | Tobacco Control | Q15766348 |
| P1476 | title | Reducing the nicotine content to make cigarettes less addictive | |
| P478 | volume | 22 Suppl 1 |
| Q54603098 | 50 years since the first Surgeon General's report on smoking and health: a happy anniversary? |
| Q91645806 | A Novel Method for Evaluating the Acceptability of Substitutes for Cigarettes: The Experimental Tobacco Marketplace |
| Q42723800 | A behavioral economic perspective on smoking persistence in serious mental illness |
| Q88728504 | Adolescent smokers' response to reducing the nicotine content of cigarettes: Acute effects on withdrawal symptoms and subjective evaluations |
| Q64966273 | Age Moderates Smokers' Subjective Response to Very-Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial. |
| Q42711015 | An endgame for tobacco? |
| Q57813914 | An enzymatic approach reverses nicotine dependence, decreases compulsive-like intake, and prevents relapse |
| Q36155938 | Annual healthcare spending attributable to cigarette smoking: an update |
| Q91812333 | Are we guilty of errors of omission on the potential role of electronic nicotine delivery systems as less harmful substitutes for combusted tobacco use? |
| Q47179523 | Attitudes towards Potential New Tobacco Control Regulations among U.S. Adults |
| Q38744516 | Behavioral Economic Laboratory Research in Tobacco Regulatory Science |
| Q64891756 | Behavioral Economic Purchase Tasks to Estimate Demand for Novel Nicotine/tobacco Products and Prospectively Predict Future Use: Evidence From The Netherlands. |
| Q35070039 | Biochemical estimation of noncompliance with smoking of very low nicotine content cigarettes. |
| Q49271444 | Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation |
| Q88971655 | Cigarette and e-liquid demand and substitution in e-cigarette-naïve smokers |
| Q47106790 | Cigarette prohibition and the need for more prior testing of the WHO TobReg's global nicotine-reduction strategy |
| Q92074516 | Community-Based Smoking Cessation Programs: A Way Forward? |
| Q37349081 | Comparative risk assessment of tobacco smoke constituents using the margin of exposure approach: the neglected contribution of nicotine |
| Q58578907 | Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes |
| Q45763670 | Development of an integrated tobacco endgame strategy. |
| Q90715939 | Differences in acute reinforcement across reduced nicotine content cigarettes |
| Q45981734 | Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms. |
| Q92194108 | Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness |
| Q35875970 | Effects of nicotine and minor tobacco alkaloids on intracranial-self-stimulation in rats. |
| Q47250729 | Electronic Cigarettes: Their Constituents and Potential Links to Asthma. |
| Q45996379 | Emerging nicotine delivery products. Implications for public health. |
| Q48808004 | Estimating Demand and Cross-Price Elasticity for Very Low Nicotine Content (VLNC) Cigarettes Using a Simulated Demand Task |
| Q52601399 | Estimation of compliance with exclusive smoking of very low nicotine content cigarettes using plasma cotinine. |
| Q41640336 | Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use |
| Q48301063 | Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi-site clinical trial. |
| Q92356407 | Knowledge Gaps around Smoking and Nicotine among U.S. Military Veterans Who Smoke and Implications for Practice |
| Q38779511 | Low nicotine content descriptors reduce perceived health risks and positive cigarette ratings in participants using very low nicotine content cigarettes |
| Q28389865 | Lung deposition analyses of inhaled toxic aerosols in conventional and less harmful cigarette smoke: a review |
| Q52304076 | Missing the biggest story in the US Surgeon General's report. |
| Q89259971 | Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation |
| Q92194172 | Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis |
| Q53622250 | Nicotine and Anatabine Exposure from Very Low Nicotine Content Cigarettes. |
| Q89352927 | Nicotine and addiction beliefs and perceptions among the US-born and foreign-born populations |
| Q35657833 | Nicotine reduction as an increase in the unit price of cigarettes: a behavioral economics approach |
| Q30244252 | Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research |
| Q46593672 | Nicotinic effects of tobacco smoke constituents in nonhuman primates |
| Q26785452 | Obese Smokers as a Potential Subpopulation of Risk in Tobacco Reduction Policy |
| Q30380558 | Predicted Impact of Nicotine Reduction on Smokers with Affective Disorders. |
| Q27312260 | Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy |
| Q47291624 | Preliminary validity of the modified Cigarette Evaluation Questionnaire in predicting the reinforcing effects of cigarettes that vary in nicotine content |
| Q35897473 | Public opinion about FDA regulation of menthol and nicotine |
| Q37502340 | Quantitation of the Minor Tobacco Alkaloids Nornicotine, Anatabine, and Anabasine in Smokers' Urine by High Throughput Liquid Chromatography-Mass Spectrometry |
| Q34496332 | Randomized Trial of Reduced-Nicotine Standards for Cigarettes. |
| Q38940275 | Ready for a goodbye to tobacco? - Assessment of support for endgame strategies on smoking among adults in a Danish regional health survey |
| Q36120193 | Reduced-Nicotine Cigarettes--A Promising Regulatory Pathway |
| Q92194047 | Research on Behavioral Discrimination of Nicotine May Inform FDA Policy on Setting a Maximum Nicotine Content in Cigarettes |
| Q37519158 | Sex differences in nicotine self-administration in rats during progressive unit dose reduction: implications for nicotine regulation policy |
| Q33855129 | Sex differences in response to reduced nicotine content cigarettes. |
| Q41971019 | Smoking Topography Characteristics of Very Low Nicotine Content Cigarettes, With and Without Nicotine Replacement, in Smokers With Schizophrenia and Controls |
| Q26782639 | Smoking cessation and reduction in people with chronic mental illness |
| Q45150453 | Smoking-related outcomes and associations with tobacco-free policy in addiction treatment, 2015-2016. |
| Q57171561 | Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science |
| Q34462263 | The Reinforcing Effects of Nicotine in Humans and Nonhuman Primates: A Review of Intravenous Self-Administration Evidence and Future Directions for Research |
| Q30811043 | The effects of nicotine self-administration and withdrawal on concurrently available chow and sucrose intake in adult male rats |
| Q37282614 | The tobacco endgame: a qualitative review and synthesis |
| Q50455473 | Threshold dose for behavioral discrimination of cigarette nicotine content in menthol vs. non-menthol smokers |
| Q39243540 | Tobacco control policies and their impacts. Past, present, and future |
| Q57476934 | Variation in Nicotine Intake Among U.S. Cigarette Smokers During the Past 25 Years: Evidence From NHANES Surveys |
| Q39343717 | What will it take to get to under 5% smoking prevalence by 2025? Modelling in a country with a smokefree goal |
Search more.